Drug Shortage Report for FOQUEST

Last updated on 2024-03-06 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2024-08-30
Actual end date
Shortage status Actual shortage
Updated date 2024-03-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v95 2023-04-05 French Compare
v94 2023-04-05 English Compare
v93 2023-03-30 French Compare
v92 2023-03-30 English Compare
v91 2023-03-27 French Compare
v90 2023-03-27 English Compare
v89 2023-03-24 French Compare
v88 2023-03-24 English Compare
v87 2023-03-17 French Compare
v86 2023-03-17 English Compare
v85 2023-03-09 French Compare
v84 2023-03-09 English Compare
v83 2023-03-02 French Compare
v82 2023-03-02 English Compare
v81 2023-02-22 French Compare
v80 2023-02-22 English Compare
v79 2023-02-16 French Compare
v78 2023-02-16 English Compare
v77 2023-02-09 French Compare
v76 2023-02-09 English Compare

Showing 61 to 80 of 155